TXNIP and Hepatic steatosis: Supporting this, Guo et al. [37] reported an association between elevated circulating TXNIP levels and fatty liver in patients with newly diagnosed T2DM, suggesting that TXNIP activation may contribute to metabolic liver disease development and progression through oxidative stress pathways.